Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Thanks to a groundbreaking genetic treatment, Sebastien Beauzile is the first person in New York to be cured of the disease.

Sickle cell disease is a genetic blood disorder characterised by the production of abnormal haemoglobin, which causes red blood cells to become rigid and sickle-shaped. These cells tend to clump ...

Next review: More evidence on exagamglogene autotemcel is being collected. After this, NICE will decide whether to recommend it for use in the NHS and update the guidance. It will be available with ...

A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers. A bone marrow transplant process co ...

A novel reduced-intensity haploidentical bone marrow transplant has shown high success in curing sickle cell disease in adults, with 95% survival and 88% cure rates two years post-transplant.

Trial at @hopkinskimmel and other centrs finds reduced-intensity haploidentical bone marrow transplant can cure sickle cell disease. › A bone marrow transplant process co-developed by investigators at ...